Colinz Laboratories has informed that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) of SEBI (LODR) Regulations, 2015, is scheduled to be held on Wednesday, 29th April, 2026 at the registered office of the Company at A-101, Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra, 400078, at 3:30 pm to consider, approve and take on record the Audited Financial Results of the Co-parry for the quarter and year ended 31st March, 2026. As intimated vide its letter dated 31st March 2026; the trading window for dealing in the securities of the Company is closed from Wednesday, 01st April, 2026 till the second trading day after the Board meeting date i.e. 29th April, 2026 for the declaration of financial results for the quarter & financial year ended March 31st, 2026. A copy of this intimation is also being made available on the Company's website at www.findoc-cll.in.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1807.25 |
| Dr. Reddys Lab | 1273.90 |
| Cipla | 1388.80 |
| Zydus Lifesciences | 1104.35 |
| Lupin | 2292.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: